Adobe announced the general availability of Adobe Real-Time CDP Collaboration in the U.S., a new offering that enables advertisers and publishers to tackle a changing advertising landscape. Brands ...

If you purchased or acquired securities in Merck between February 3, 2022 and February 3, 2025 and would like to discuss your ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and ...

Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...

NEW YORK/FRANKFURT (Reuters) - Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and rare diseases drugmaker SpringWorks ...

Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites by the ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...